Target intelligence / Profile preview

Kinesin-like protein KIF21B (KIF21B)

Target
KIF21B
Molecular classification
Kinesin, Motor protein, Microtubule-associated protein
01

Overview

Kinesin-like protein KIF21B (KIF21B) is a member of the kinesin-4 family of microtubule-associated motor proteins that play essential roles in regulating microtubule dynamics and intracellular transport, particularly in neurons[1][3][4][7]. KIF21B is a processive, plus end–directed motor that accumulates at microtubule plus ends, inducing growth pausing and modulating dendritic architecture by restricting microtubule extension[1][3][4]. It is highly expressed in the central nervous system, with a particularly strong presence in neurons' axons and dendrites, where it is critical for dendritic arbor complexity, synaptic transmission, and synaptic plasticity, including the regulation of NMDA receptor–dependent long-term depression [3][4][7]. Loss-of-function or mutation of KIF21B results in impaired neuronal growth and connectivity, and genetic alterations in KIF21B have been implicated in neurodevelopmental disorders, cognitive dysfunction, multiple sclerosis, and association with neurodegenerative diseases such as Alzheimer's [3][5][7]. Although no approved drugs selectively target KIF21B, its biological importance in neural function and disease association make it a potential therapeutic target, but with substantial safety concerns given its central role in neuronal transport and plasticity[3][4][7].

Other names
Kinesin family member 21BKIF21BKIAA0449DKFZP434J212
02

Mechanism of action

Not directly drugged; functional modulation via microtubule engagement and protein-protein interactions

03

Biological functions

Intracellular transportRegulation of microtubule dynamicsNeuronal morphology regulationSynaptic plasticity (modulation of synaptic function)
04

Disease associations

Neurodegenerative diseaseNeurodevelopmental disordersCognitive dysfunctionMultiple sclerosisAlzheimer’s disease
05

Safety considerations

Therapeutic targeting could interfere with neuronal transport and plasticity, risking neurotoxicity or cognitive effects
06

Biomarkers

Expression (mRNA/protein) in neurons, especially in neurodegenerative and neuroinflammatory conditions

Beyond the preview

Go deeper on Kinesin-like protein KIF21B (KIF21B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin-like protein KIF21B (KIF21B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call